Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Traders beef up on Herbalife options as shares extend losses

Page 1 of 2

Traders beef up on Herbalife options as shares extend lossesHerbalife Ltd. (NYSE:HLF) – Options on Herbalife continue to change hands at a clip on Thursday, one day after Pershing Square Capital Management founder, Bill Ackman, announced a short position in the stock that sent shares in the marketer of weight management products down as much as 15% during trading on Wednesday. The stock extended losses today, sliding 8% in the early going to $34.33, the lowest level since February 2011. Upwards of 71,000 put and call options have changed hands on Herbalife Ltd. (NYSE:HLF) as of 12:55 p.m. ET, with around 1.5 puts changing hands on the stock for each single call option in play. Some traders appear to be positioning for shares in the name to hit lower lows by the end of this week, while others establish contrarian bets on the name that benefit from a pop in the price of the underlying during the next 24 hours. Bears anticipating a sharp drop in shares of Herbalife Ltd. (NYSE:HLF) in the very near term appear to be buying out-of-the-money puts across several strike prices in the December expiry. Meanwhile, call buying at the Dec. $35, $37.5 and $40 strikes looks for the stock to rebound substantially by expiration.

Illumina, Inc. (NASDAQ:ILMN) – Shares in biotechnology company, Illumina, Inc. (NASDAQ:ILMN), jumped 9.25% this morning to a new 52-week high of $57.00 on unconfirmed reports that Swiss drug maker, Roche Holding AG, may be in talks to purchase Illumina at a substantially sweetened price of $66.00 a share or $8.1 billion. San Diego, California-based Illumina’s shares have rallied more than 80% since the start of the year on speculation the provider of DNA sequencing technology may be acquired. Options volume on Illumina, Inc. (NASDAQ:ILMN) is up sharply on the session, with some 14,000 contracts in play on the stock as of midday in New York, versus average daily options volume of around 2,200 lots. A number of strategists appear to be buying upside calls on the takeover chatter, snapping up in- and out-of-the-money calls in the December and January expiries. The Dec. $55 and $57.5 strike calls, which have one full trading session remaining to expiration, attracted buyers in the early going. Trading traffic in call options expiring the third Friday of the New Year are looking for shares in the name to rise sharply during the next four weeks. Options players appear to have purchased approximately 1,000 calls at the Jan. 2013 $62.5 strike calls for an average premium of $0.96 apiece. Buyers of these contracts profit at expiration next month should shares in Illumina, Inc. (NASDAQ:ILMN) rally another 11% to top the average breakeven price of $63.46. Traders also picked up around 600 of the Jan. 2013 $65 strike calls at an average premium of $0.45 each, and may profit in the event of a 15% move to the upside to exceed $65.45 by expiration.

Page 1 of 2
Loading Comments...